Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visitSyneosHealth.com.
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. Founded by two Harvard Medical School faculty members, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real-world data. By using our proprietary technology, advanced analytics and deep expertise to organize complex data, we provide a comprehensive picture of cancer that can be used to advance care and research. We believe that everyone touched by cancer deserves a clear path to care. Together, we can make that vision a reality.
Adelphi Real World: Experts in the generation of real-world data and shaping of real-world evidence. Conducting multi-country real-world observational studies and healthcare database analyses for over 20 years, our services are grounded in the extensive heritage afforded by Adelphi’s proprietary Disease Specific Programmes™ and supported by the expansion of our real-world evidence services. Data has supported over 900 publications in peer-reviewed journals & scientific congresses alongside informing therapy guideline evolution & supporting regulatory submissions